.jpg)
The focus on accelerated development of new modalities for advanced therapies and challenges with complex drug candidates has driven the adoption of novel concepts and technologies in pharmaceutical development and manufacturing.
Watch Now
The pharma industry is 55 per cent more emission-intensive than the automotive industry, according to the report titled, Carbon footprint of the global pharmaceutical industry and relative impact of its major players. At the same time regulators and society demand safe, affordable and accessible healthcare globally.
Watch Now
Ambry Genetics
This webinar will review clinical and genetic risk factors for contralateral breast cancer in patients who have been newly diagnosed with breast cancer. A specific focus on the role of family history and genetic mutations on contralateral breast cancer risk will be outlined. The role of risk models and how to apply these and other prediction tools in the clinical setting will be reviewed.
Watch Now
.jpg)
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians.
Watch Now